Regeneron

YTD

ALL

Trade Regeneron 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About REGN

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.

CEO

Leonard S. Schleifer

CEOLeonard S. Schleifer

Employees

15,106

Employees15,106

Headquarters

Tarrytown, New York

HeadquartersTarrytown, New York

Founded

1988

Founded1988

Employees

15,106

Employees15,106

REGN Key Statistics

Market cap

52.85B

Market cap52.85B

Price-Earnings ratio

15.41

Price-Earnings ratio15.41

Dividend yield

0.15%

Dividend yield0.15%

Average volume

1.43M

Average volume1.43M

High today

$560.00

High today$560.00

Low today

$485.00

Low today$485.00

Open price

$516.00

Open price$516.00

Volume

6.31M

Volume6.31M

52 Week high

$1,211.20

52 Week high$1,211.20

52 Week low

$485.00

52 Week low$485.00

REGN News

Simply Wall St 2d

Regeneron Pharmaceuticals (NasdaqGS:REGN) Adopts Innovative Technology for Faster Drug Discovery

recently entered a licensing agreement with Telesis Bio Inc. to implement the Gibson SOLA™ platform, aiming to boost the company’s efficiency in the biotech sec...

Analyst ratings

74%

of 27 ratings

Buy

74.1%

Hold

22.2%

Sell

3.7%

People also own

Based on the portfolios of people who own REGN. This list is generated using Robinhood data, and it’s not a recommendation.